DoctorDirectory.ai
Menu

Dr. Anjay Rastogi, MD

Not yet claimed

Nephrologist · Physician (MD)

Los Angeles, CA

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Anjay Rastogi? Claim this profile.

Anjay Rastogi is a kidney doctor at UCLA Health and leads its CORE Kidney program. He cares for people with chronic kidney disease.

About Dr. Anjay Rastogi, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Anjay Rastogi is a nephrologist (kidney doctor) in Los Angeles. He is a Professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, and he sees patients through UCLA Health, including at the Connie Frank Kidney Transplant Center and General Nephrology.

He earned his medical degree at SMS Medical College in Jaipur, India, in 1993, and holds a PhD in pharmacology. He completed his internal medicine residency and nephrology fellowship at UCLA, where his graduate training was under Nobel laureate Louis Ignarro. His UCLA profile and a physician directory list him as board certified in nephrology.

He founded the UCLA CORE Kidney Health Program in 2016 and directs it. He also directs UCLA's nephrology clinical research program and serves as medical director for the ESRD/dialysis program and the living kidney donor program. The CORE Kidney program runs public education through a YouTube channel with his lectures and a monthly patient chat that people can register for.

Open Payments records from CMS show $1,636,212.79 in industry payments to him across 1,953 records for 2021-2025. Top payers include AstraZeneca, Bayer HealthCare Pharmaceuticals, Genzyme, Fresenius, and Vifor Pharma. Payments from drug and device companies to doctors are legal and common, and often reflect research funding, consulting, or speaking work.

Clinical Chief of Nephrology at UCLA
He is a Professor and the Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA. uclahealth.org
Founded CORE Kidney Program
He founded the UCLA CORE Kidney Health Program in 2016 and serves as its director. uclahealth.org
Board certified in nephrology
His UCLA profile and a physician directory list him as board certified in nephrology. uclahealth.org
MD and PhD training
He received his medical degree from SMS Medical College in Jaipur, India, in 1993, and holds a PhD in pharmacology. He trained in internal medicine and nephrology at UCLA. phppd.providence.org
Dialysis and transplant leadership
He is medical director of UCLA's ESRD/dialysis program and its living kidney donor program, and directs the nephrology clinical research program. doximity.com
Free patient education talks
The CORE Kidney YouTube channel carries his lectures on topics such as peritoneal dialysis and chronic kidney disease, plus a registration link for a monthly patient chat. youtube.com
Industry payments reported
CMS Open Payments lists $1,636,212.79 across 1,953 records for 2021-2025, with AstraZeneca, Bayer, Genzyme, Fresenius, and Vifor among the largest payers. openpaymentsdata.cms.gov

Worth knowing

  • CMS Open Payments reports $1,636,212.79 in industry payments across 1,953 records for 2021-2025. Such payments are legal and common, and patients who want to know whether a company relationship relates to a medication they are prescribed can ask directly. openpaymentsdata.cms.gov
  • One insurer directory lists his board certifications as 'Not Provided,' while the UCLA profile and another directory list nephrology board certification. phppd.providence.org
  • A secondary directory lists his California medical license as active through 2027; the researcher did not complete verification against the state medical board's primary records. health.usnews.com

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$1,636,213

1,953 payments

2021$291,173
2022$337,065
2023$322,807
2024$375,489
2025$309,678

Top payers

  • AstraZeneca Pharmaceuticals LP$291,475
  • Bayer HealthCare Pharmaceuticals Inc.$176,457
  • GENZYME CORPORATION$156,168
  • Fresenius USA Marketing, Inc.$143,913
  • Vifor Pharma, Inc.$130,550

Payment types

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$959,798
  • Travel and Lodging$253,832
  • Consulting Fee$243,297
  • Honoraria$69,800
  • Food and Beverage$56,297

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: uclahealth.org · uclahealth.org · uclahealth.org · phppd.providence.org · health.usnews.com · doximity.com · linkedin.com · youtube.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·